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ABSTRACT 
Intensity Modulated Radiotherapy (IMRT, step and shoot) is emerging as the standard of care in non-small cell lung cancer (NSCLC) 
patient treatments. Volumetric Arc Therapy (VMAT) delivered with two arcs offers fast and homogeneous dose delivery with known 
limitations of increased volumes of low dose. The aim of this study is to define whether Hybrid volumetric arc IMRT (HA-IMRT: IMRT 
and VMAT combination) offers a superior dose distribution over IMRT without the limitations found in VMAT delivery alone. Ten (previ-
ously 4DCT planned) locally advanced NSCLC patients treated by IMRT to 70 Gy in 35 fractions were retrospectively re-planned using 
the HA-IMRT technique. Respiratory correlated imaging (3 mm slice thickness) were generated utilizing the Philips Large Bore 16 slice 
CT Scanner (Phillips, Inc.). Treatment planning was performed using The Philips Pinnacle Treatment  Planning System v. 9.0 (Philips 
Medical, Cleveland, OH).  The PTV was defined as the Integrated Tumor Volume (ITV= internal GTV contoured on all respiratory data 
sets plus 8 mm margin for all histologies) with a 4 mm margin added.  Lung parenchyme was defined and contoured using the 50% 
phase. Conventional IMRT plans used 6:8 non coplanar or coplanar fields and VMAT plans were generated using two 1800 arcs. HA-
IMRT  plans were generated using a  combination of 60% conventional IMRT with 40% VMAT. The maximum dose (Gy) to the spinal 
cord, V5, V10, V20 for total lung, V20 and V30 for the ipsilateral lung, V30 for heart, V50and V70 for esophagus, and the V77 for the 
Clinical Treat Volume (CTV) were compared for all techniques utilizing the Dose Volume Histograms. In addition, total monitor units 
(MU), total treatment time (TT) and the conformality index (CI) were compared. . Conventional IMRT delivers less low dose to the lung 
compared to VMAT alone. (V5 VMAT (V5: 55.0% vs 63.0%, p= 0.005; V10: 41.4% vs 43.9%, p= 0.018). However, VMAT is superior 
in total lung V20 (V20:30.6% vs 29.3% p= 0.010), ipsilateral lung doses (V20:55.5% vs 52.8% p= 0.008; V30: 46.1% vs 42.9% p= 
0.012), and in heart sparing. (V30: 21.09% vs 17.78% p= 0.015; MHD: 15.92% vs 14.81% p= 0.021). It is also superior in conformality 
(CI 1.51 vs 1.26 p= 0.005) and treatment delivery is faster ( 293 min vs 108 min p= 0.005) with lower MUs (24805 vs 19141  p= 0.005). 
HA-IMRT  was found to be superior to VMAT in terms of total lung low dose volumes (V5:58.1% vs 63.0%, p= 0.005; V10:42.2% vs 
44.9%, p= 0.027), superior to IMRT for ipsilateral lung doses (V20: 53.6% vs 55.5%, p= 0.007; V30: 43.4% vs 46.1%, p= 0.018), and 
superior in treatment time (199 min vs 293 min, p= 0.005) with lower MU’s (22155 vs 24805, p=.005). Overall, HA-IMRT provides a 
more homogenous dose distribution (CTV: V77: 0.55% vs 2.1% vs 1.7%, p= 0.000) compared to IMRT and VMAT alone. All three 
plans provided comparable esophagus and spinal cord Organ at Risk (OAR) doses. HA-IMRT seems to combine the benefits of both 
conventional IMRT and VMAT; such as to deliver a faster, more conformal, homogeneous treatment in comparison to ssIMRT, and to 
deliver lower dose to lung in comparison to VMAT.
Keywords: VMAT, IMRT, Hybrid, Stage III lung cancer
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INTRODUCTION
Chemotherapy and Radiotherapy are accepted as 
“standard of care” for many locally advanced non-
small cell lung cancer (NSCLC) patients.1,2 Stand-
ard radiation prescription doses have remained 60-
63 Gy for more than 30 years except at a couple of 
comprehensive cancer institutions.2 Recently, anal-
ysis of seven different Radiation Therapy Oncol-
ogy Group (RTOG) trials of chemo- radiotherapy 
for locally advanced NSCLC revealed improved 
survival and loco-regional control with dose esca-
lation.3 Despite the benefits of radiotherapy, local 
control rates remained poor with standard doses 
leading to dose escalation to decrease local failure 
of disease, and to eliminate the primary source for 
distant metastases. However, the preliminary find-
ings of RTOG 0617 comparing standard-dose (60 
Gy) versus high-dose (74 Gy) conformal radiother-
apy with concurrent chemotherapy for stage IIIA/
IIIB non-small cell lung cancer showed no survival 
benefit of dose escalation with 3DCRT or IMRT 
based on enrolling departments awaiting the tech-
nical analysis.4 This triggers the question of safe 
delivery of radiotherapy with developing technol-
ogy in era of intensity modulated radiotherapy 
(IMRT), and volumetric arc radiotherapy (VMAT). 
IMRT has been becoming the standard radiation 
treatment technique over the last decade, with the 
consequence of increased treatment time and the 
benefit of improved conformality and normal or-
gan sparing.5 Recent secondary analysis of RTOG 
0617 on impact of IMRT for Locally Advanced 
NSCLC supported the routine use of IMRT due to 
its impact on lower rates of severe pneumonitis and 
ÖZET
Küçük Hücreli Dışı Akciğer Kanserli Hastaların Tedavisinde Hibrid Volümetrik Ark Radyoterapi, Yoğunluk Ayarlı Rady-
oterapi Ve Volumetrik Yoğunluk Ayarlı Ark Radyoterapisinin Avantajlarını Birleştirerek, Hızlı, Konformal ve Homojen bir 
Tedaviyi Düşük Doz Banyosundan Sakınarak Yapabilmektedir: Dozimetrik Çalışma
Küçük hücreli dışı akciğer kanserli (KHDAK) hastaların tedavisinde, Yoğunluk Ayarlı Radyoterapi (Step and shoot: YART) ve  Volumetrik 
Yoğunluk Ayarlı Ark Terapisi (VMAT) giderek daha fazla kullanılmaktadır. Bu çalışmanın amacı, Hibrid volümetrik ark YART’ın (HA-YART: 
YART ve VMAT kombinasyonu) tek başına VMAT tedavisinde gözlenen sınırlamalar olmaksızın, YART tedavisinden çok daha iyi bir 
doz dağılımı sunup sunmadığını belirlemektir. Dört Boyutlu Bilgisayarlı Tomografi (4BBT) ile planlı, daha önceden YART ile 35 fraksi-
yon ile 70 Gy uygulanarak tedavi edilmiş lokal ileri evre KHDAK’li 10 hasta, HA-YART tekniği kullanılarak retrospektif olarak yeniden 
planlanmıştır. Philips Large Bore 16 dilimli BT (Phillips, Inc.) kullanılarak solunum kontrollü görüntüler (3mm kesit kalınlığı), Philips Pin-
nacle Tedavi Planlama Sistemi v.9.0 (Philips Medical, Cleveland, OH) kullanılarak tedavi planlamaları gerçekleştirilmiştir. PTV, İntegral 
Tümör Hacmine (ITV = tüm solunum fazlarında  konturlanan GTV + tüm histolojiler için 8 mm) 4 mm marj eklenerek tanımlanmıştır. 
Akciğer parankimi solunumun %50 fazında en küçük hacimde konturlanmıştır. Konvansiyonel YART planlarında, non-coplanar ya 
da coplanar 6:8 alanlar kullanılırken VMAT planları iki adet 180° arklar ile oluşturulmuştur. HA-IMRT planları için %40 VMAT ile %60 
konvansiyonel YART  kombinasyonu kullanılmıştır. Spinal kord için maksimum doz (Gy), toplam akciğer için V5, V10 ve V20, ipsilateral 
akciğer için V20 ve V30, kalp için V30, yemek borusu için V50 ve V70, klinik tedavi hacmi (CTV) için V77 değerleri tüm teknikler için Doz 
Hacmi Histogramları (DVH) kullanılarak karşılaştırılmıştır. Ayrıca toplam monitör ünitleri (MU), toplam tedavi süresi (TT) ve konformalite 
indeksi (CI) farklarına bakılmıştır. Konvansiyonel YART, VMAT’a göre daha az akciğer düşük doz değerleri sağlamaktadır (V5: 55.0% vs 
63.0%, p= 0.005; V10:41.4% vs 43.9% p= 0.018). Bununla birlikte, VMAT riskli organların korunmasında kritik eşikler gözetildiğinde, 
total akciğer V20’sinde (V20:30.6% vs 29.3% p= 0.010), ipsilateral akciğer dozlarında (V20:55.5% vs 52.8% p= 0.008; V30:46.1% 
vs 42.9% p= 0.012) ve kalp dozlarında (V30: 21.09% vs 17.78% p= 0.015; MHD: 15.92% vs 14.81% p= 0.021) daha üstündür; 
aynı zamanda üstün konformalite (CI 1,51 vs 1,26 p= 0.005) ve düşük MU (24805 vs 19141  p= 0.005) ile tedaviyi daha hızlı tamam-
layabilmektedir (293 dak. vs 108 dak. p= 0.005). HA-YART’ın ise toplam akciğer düşük doz hacimleri (V5:58.1% vs 63.0%, p=.005; 
V10:42.2% vs 44.9%, p= 0.027) bakımından VMAT’dan daha üstün olduğu, ipsilateral akciğer dozlarında (V20:53.6% vs 55.5% p= 
0.007; V30: 43.4% vs 46.1% p= 0.018), daha az toplam MU (22155 vs 24805 p= 0.005) ve daha kısa toplam tedavi süresiyle (199 dak 
vs 293 dak p= 0.005)  IMRT’den üstün olduğu izlenmiştir. Genel olarak, HA-IMRT tek başına YART ve VMAT ile karşılaştırıldığında daha 
homojen (CTV: V77:0.55% vs 2.1% vs 1.7%, p= 0.000) bir doz dağılımı sağlamaktadır. Her üç plan, kabul edilebilir ve benzer özofagus 
ile omurilik dozları sağlamıştır. HA-YART, ssYART’a kıyasla hızlı, daha konformal ve homojen bir tedavi sunmak için ve VMAT’a kıyasla 
daha az miktarda akciğeri daha düşük bir dozda ışınlamak için, hem geleneksel YART’ın hem de VMAT’ın faydalarını bir araya getirebilir.
Anahtar Kelimeler: VMAT, IMRT, Hibrit, Evre III akciğer kanseri
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cardiac doses.6 VMAT is a relatively new treatment 
option which is an arc-based IMRT tecnique with 
a full 360 degrees of beam directions available 
for optimization. Preliminary results for treatment 
plans generated with VMAT optimization have dis-
played equivalent or superior dose distributions to 
static gantry IMRT plans.7,8 
VMAT offers fast and homogeneous dose deliv-
ery with few studies on VMAT plan quality for 
stage III lung cancer. Quan et al. investigating an 
M.D. Anderson study of the emerging application 
of VMAT for stage III lung cancer in an automat-
ed way.9 In a study of comparision of intensity-
modulated radiotherapy (IMRT) and volumetric-
modulated arc therapy (VMAT)  plans consisting 
125 non-small cell lung cancer (NSCLC) patient’s 
plans demostrated that  IMRT may be better for 
NSCLC patients with poor pulmonary function 
while  VMAT may be advised for NSCLC patients 
with normal pulmonary function.10 However, in-
creased volumes of low dose compared to step and 
shoot IMRT (ssIMRT) is a limitation.
A combination of traditional conformal radio-
therapy and double arc VMAT called the Hybrid 
rapid arc tecnique7 was evaluated by Chan et al to 
overcome the lung low dose bath.  Superior do-
simetry was demonstrated when compared with 
conformal radiotherapy and VMAT alone, while a 
hybrid IMRT (static plus IMRT beams treated con-
currently) technique was noted to demonstrate ad-
vantages for reduction of low dose to lung.11 Based 
on those studies, we investigated whether Hybrid 
volumetric arc therapy as a combination of IMRT 
and VMAT (Hybrid ARC:  IMRT and VMAT com-
bination) offers a superior dose distribution over 
IMRT without the shortcomings  of VMAT deliv-
ery alone. 
MATERIAL AND METHODS 
The planning 4D computerized tomography (4D 
CT) scans of ten consecutive stages IIIA- IIIB 
(UICC 6th Edition) NSCLC patients treated by 
definitive IMRT to 70 Gy in 35 fractions at our in-
stitution were retrieved. The details of simulation, 
volume definition, planning and comparison are 
given below.
Simulation
All patients were simulated in the supine position 
in  a customized vac loc  bed in addition to T-bar, 
Wing-board, and knee-foot stopper immobilization 
(CIVCO, Kalona, Iowa). 4-D and contrast free-
breathing axial CT scans with 3 mm slice thickness 
from the mandible to the umbilicus were obtained 
with the Philips Brilliance Big Bore 16 slice CT 
 
Figure 1. Field arrangements for (a) ssIMRT, (b) VMAT, (c) Hybrid –arc(ssIMRT+VMAT)
A  C B  
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(Phillips,Inc.). Respiratory correlated imaging was 
generated for planning which was performed us-
ing the Philips Pinnacle Treatment planning sys-
tem (9.0, Philips Medical Systems Inc. Cleveland, 
OH) which uses Collapse Cone Convolution [cc] 
algorithm.  
Volume Definition
The Internal GTV (iGTV) was contoured based 
on acquired 4D CT (Respiratory data sets are 
“binned” by phase: 0 - 100% at 10% interval).  The 
clinical tumor volume (CTV) defined as Internal 
Target Volume (ITV) was generated by adding an 8 
mm margin to the iGTV for all histologies. A PTV 
was generated by adding another 4 mm margin to 
the ITV.   All OARs were delineated on the average 
dataset while the lung parenchyme was contoured 
on the 50% phase for dose volume evaluation.  The 
planning risk volume (PRV) for the spinal cord was 
created by adding a 0.5 cm margin to the contoured 
spinal cord.
Planning 
The prescription dose for all cases was 70 Gy in 
35 fractions given over 7 weeks. The planning ob-
jective was to cover the PTV by at least 95% of 
the prescribed isodose, and CTV by 98% of the 
prescribed isodose line. Identical objectives were 
set for IMRT and VMAT plans. As previously pre-
scribed radiotherapy was concurrent with chemo-
therapy, the planning objectives were as follows: 
The maximum point dose to the spinal cord was 
less than 45 Gy, Spine ≤ 45Gy, volume of lung 
minus GTV receiving more than 20 Gy  (V20) 
≤ 35%, 10 Gy(V10) ≤  45%, 5 Gy (V5) ≤  65%, 
mean lung dose (MLD)  ≤ 20Gy; volume of heart 
receiving more than 30 Gy (V30) ≤ 45%, mean 
heart dose (MLD)  ≤ 26Gy, The maximum point 
dose to Esophagus ≤80Gy, volume of Esophagus 
receiving more than 70 Gy (V70) ≤ 20%, 50 gy 
(V50) ≤ 40%, mean Esophagus dose  ≤ 34Gy. The 
treatment plans were generated utilizing the  6 MV 
Photon beam from the Varian Triology 120 leaf 
millennium multileaf collimator (MLC) (Varian 
Medical Systems, Palo Alto, CA). Plans were de-
livered with a maximum dose rate of 600 MU/min. 
All calculations utilized a calculation of grid size 
of 0.3 x 0.3 x 0.3 cm3. In order to rule out inter-
observer variability, all plans were performed by 
a single physicist (YS). Figure 1 displays the field 
arrangements for three different plans.
ssIMRT
Treated step and shoot IMRT plans were generated 
according to our clinical practice using 6-8 non co-
planar or coplanar beams. Multiple segments (90-
120) were created using the direct machine param-
eter optimization (DMPO) algorithm in Pinnacle.12
VMAT
VMAT plans were generated using double partial 
(1800) arcs with the same isocenter rotating clock-
wise and counter clockwise starting from 3580 and 
1780 with a 150 and 3450 collimator angle.  Each 
of double partial (1800) arcs was used for planning 
instead of a whole 3600 arc to reduce lung paren-
chyma dose. Collimator angle was fixed to 150 and 
3450 to minimize the effects of interleaf leakage 
and tongue-and-groove effect. Multiple control 
points which have 360 segments in double partial 
arc were created using the smart arc  optimiza-
tion (SmartArc) algorithm in Pinnacle. The con-
trol point described gantry speed, dose rate, total 
treatment time and leaf travel speed. For both the 
ssIMRT and VMAT plans the same dose objectives 
and weightings were used. 
Hybrid arc IMRT ( HA-IMRT: ssIMRT and 
VMAT combination)
The HA-IMRT technique integrates IMRT and 
VMAT. HA-IMRT plans were generated as a com-
posite plan of 60% IMRT (IMRT plan for full 70 
Gy in 35 fractions) and 40% VMAT (VMAT con-
sisted of double partial arc plan for full 70 Gy in 35 
fractions) combination. This combination is based 
on an improvised decision ratio. The aim of com-
bining the both plans with this fixed ratio was to 
minimize the low dose bath and direct OAR expo-
sure within the fields without compromising from 
the balance and benefits of both IMRT and VMAT. 
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Table 1. Dosimetric comparisons of three planning techniques for local advanced lung cancer patients
 ssIMRT VMAT HA-IMRT p value  
Total Lung 20.31 19.82 19.83 a 0.060
Mean Dose (Gy)    b 0.968
    c 0.012
V5 55.05 63.00 58.18 a 0.001
    b 0.001
    c 0.001 
V10  41.40 43.90 42.20 a 0.011
    b 0.049
    c 0.011
V20 30.06 29.30 29.8 a 0.002
    b 0.002
    c 0.063
 
Ipsilateral Lung  32.07 30.61 30.92 a 0.001
   Mean Dose (Gy)    b 0.149
    c 0.002
V20 55.5 52.88 53.60 a 0.007
    b 0.140
    c 0.014 
V30 46.1 42.99 43.49 a 0.009
    b 0.363
    c 0.014 
Heart  15.92 14.81 15.20 a 0.027
  Mean Dose (Gy)    b 0.043
    c 0.033
V30 21.09 17.78 18.72 a 0.004
    b 0.845
    c 0.043 
 
Esophagus    34.50 34.15 34.27 a 0.548
  Mean Dose (Gy)    b 0.559
    c 0.569
Maximum Dose (Gy) 75.70 74.25 74.10 a 0.032
    b 0.710
    c 0.003
V50  42.3 40.50 40.88 a 0.114
    b 0.548
    c 0.559
V70 14.03 11.76 12.35 a 0.131
    b 0.099
    c 0.264
 
Spinal cord   42.36 42.07 42.04 a 0.665
  Maksimum dose (Gy)    b 0.414
    c 0.928 
 
Clinic Tumor Volume 
V77 2.15 1.74 0.55 a 0.583
    b 0.074
    c 0.004 
Conformality Index 1.51 1.26 1.33 a 0.000
    b 0.001
    c 0.000
Total treatment Time (min) 292.97 108.40 199.70 a 0.005
    b 0.005
    c 0.005
Monitor Units 24805 19141 22155 a 0.005
    b 0.005
    c 0.005
Note:  (a)ss IMRT vs VMAT, (b) VMAT vs HA-IMRT, (c) ssIMRT vs HA-IMRT
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The same optimization objectives and planning pa-
rameters were used for the HA-IMRT, VMAT, and 
ssIMRTplans.
Dosimetric Comparison
The comparison between the plans based on analy-
sis of  dose volume histograms was performed for 
the maximum dose (as Gy) to the spinal cord; V5, 
V10, V20 for total lung; V20, V30 for the  ipsi-
lateral lung; V30 for the heart; V50, V70 for the 
esophagus. In addition, the conformality index 
(CI); and V77 for clinical target volume (CTV) 
were compared for all three techniques. Finally, 
total treated monitor units (MU: sum of delivery 
of all fractions); total treatment time (TT: sum of 
delivery of all fractions) were also compared. The 
three different techniques were compared, statisti-
cally using a two-tailed pair wise Wilcoxon signed-
ranked tests. A value of p< 0.05 was considered to 
indicate statistically significant differences. 
RESULTS
Table 1, illustrates the comparisons of the dosimet-
ric parameters for the three different planning tech-
niques: IMRT, VMAT and HA-IMRT. The dose 
distributions in coronal planes of the three plans 
are shown in Figure 2.
Lung Doses
ssIMRT treated less amount of lung to a lower 
dose compared to VMAT (V5: 55.0% vs 63.0%, p= 
0.005; V10:41.4% vs 43.9% p= 0.018). However 
VMAT yielded lower lung V20 doses (V20:30.6% 
vs 29.3% p= 0.010). The mean dose to the total lung 
in the both planes were found to be similar with no 
significant differences (MLD: 20.3% vs 19.8% p= 
0.05).  The VMAT technique spared the ipsilateral 
lung by decreasing V20 and V30 (V20:55.5% vs 
52.8% p= 0.008; V30 :46.1 % vs 42.9% p= 0.012). 
Hybrid arc was found to be superior in comparison 
to VMAT in terms of low dose volumes to total 
lung (V5:58.1% vs 63.0%, p=.005; V10:42.2% 
vs 43.9%, p= 0.049), while superior to ssIMRT 
in ipsilateral lung doses (V20:53.6% vs 55.5%,p= 
0.007; V30: 43.4% vs 46.1%, p= 0.018). Mean 
doses of total lung (TL) and ipsilateral lung (ILL) 
were lower and also similar to both VMAT and 
HA-IMRT compared to ssIMRT (TL-19.8 Gy,19.8 
Gy, 20.3 Gy,p:0.88; ILL: 30.6 Gy, 30.9 Gy, 32.0 
Gy, p= 0.139).
Other Organs at Risk
VMAT allows greater sparing of the heart (V30: 
17.78% vs 21.09% p= 0.015; MHD: 14.81% vs 
15.92% p= 0.021) in comparison to ssIMRT. Hy-
   
Figure 2. Coronal view of isodose distribution for 70 Gy (a) ssIMRT, (b) VMAT, (c) Hybrid –arc (ssIMRT+VMAT) plans of 
a representative patient
A  C  B  
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brid arc provided significantly better heart V30 and 
(mean doses compared to the ssIMRT was used 
here alone).
The maximum dose to the spinal cord was less than 
45 Gy, and was obtained in all of the plans regard-
less of planning technique (42.3 Gy for IMRT, 42.0 
Gy for VMAT and 42.0 Gy for HA-IMRT). 
All three plans provided acceptable and compara-
ble esophagus DVH results, V50, V70, maximum 
and mean doses.
Delivery
The CI was 1.51, 1.26 and 1.33 for IMRT, VMAT 
and HA-IMRT planning, respectively (Table 1). 
VMAT was proved to be more conformal respect 
to the CI values (p= 0.005),  faster (108 min vs 293 
min, p= 0.005) with lower MUs (19141vs 24805 
p= 0.005) in comparison to ssIMRT. Hybrid arc 
was found to be superior to ssIMRT in terms of to-
tal treatment time (199 min vs 293 min, p= 0.005) 
with lower MU (22155 vs 24805, p= 0.005). Over-
all, HA-IMRT provided more homogenous dose 
distrubiton (CTV V77:0.55% vs 2.1% vs 1.7%, p= 
0.004) in comparison to IMRT, but it was similar to 
VMAT alone (p= 0.074).  
DISCUSSION
Radiotherapy plays an indispensable role in treat-
ing locally advanced NSCLC.3 The innovations in 
the radiation therapy of NSCLC such as IMRT and 
VMAT, compared with previous 3DCRT methods, 
can deliver higher doses, more conformably and 
precisely to the tumor while minimizing doses to 
organs at risk. These factors could possibly lead 
to decrease morbidity and increased local control. 
Therefore, dose escalation has been a topic investi-
gated using 3DCRT, IMRT, and particle therapy in 
ongoing randomized trials for stage III NSCLC.2 
VMAT is a novel radiation technique, which can 
achieve highly conformal dose distributions with 
improved target volume coverage and sparing of 
normal tissues compared with conventional radio-
therapy techniques.  In this study, we compared 
our routine ssIMRT with VMAT and HA-IMRT 
techniques. We investigated the clinically practi-
cal and implementable combination of VMAT and 
ssIMRT to see if there was improvement in con-
formity, better sparing of OARs, and to decrease 
treatment time and to avoid the low dose bath. This 
study revealed that HA-IMRT could combine the 
benefits of IMRT and VMAT to deliver a faster, 
more conformal, homogeneous treatment in com-
parison to ssIMRT with less amount of lung irradi-
ated to a lower dose in comparison to VMAT. Our 
study is different than other hybrid studies because 
we are trying to optimize together with each treat-
ment techniques in total dose and OAR constraints 
such as simultaneously integrated treatment tech-
niques.11,24
IMRT studies have shown improvements over 3D-
CRT planning with respect to tumor dose escalation 
and doses to OARs.13 However, this gain seemed to 
be at a cost of longer treatment time which could 
lead to intra-fraction variations.11,14 In our analyses, 
HA-IMRT reduced the total treatment time, such as 
almost one third (33%), in comparison to ssIMRT. 
The clinical use of VMAT has been increasing sig-
nificantly and the majority of published data on 
VMAT consist of planning and feasibility studies. 
The clinical outcome is maturing in several sites 
including prostate, pelvis (lower gastrointestinal, 
gynecological), head and neck, thoracic, central 
nervous system, breast and other tumor sites.15 
Double arcs instead of a single arc have been 
shown to provide more homogenous and confor-
mal dose distribution in thoracic malignancies,8 
We also used double arcs VMAT in this study by 
rotating it clockwise and counter clockwise start-
ing from 3580 and 1780 (collimator angle was 150). 
Esophagitis, in the radiation treatment of locally 
advanced lung cancer, is a major dose-limiting 
acute side effect directly related with the volume 
treated.14,16 Multiple studies have shown the poten-
tial help for esophageal sparing with IMRT over 
3-DCRT.16,17 The strongest predictors of esopha-
geal toxicity was found to be V10< 65% and es-
ophageal Dmax>55 Gy.[18] Esophagus sparing is 
also found  in the literature to be obtained by using 
VMAT planning.18 In our study we kept the maxi-
mum esophageal doses similar to each technique 
and were lower than 55 Gy. Therefore no signifi-
cant difference was found in terms of this organ.
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The second major concern has been pneumonitis 
which is dose limiting. As IMRT plans have re-
duced V5, V10, V20 and MLD in comparison to 
3D-CRT plans, Yom et al noted a fourfold decrease 
in grade 3 or more pneumonitis by IMRT despite 
larger gross tumor volume (8% vs 32%) while 
they concluded that the most effective indicator 
for pneumonitis was keeping V5< 60 Gy [19]. The 
toxicity rates was also reported to be significantly 
lower in the IMRT and 4D-CT group than in the 
3D-CRT group.20 IMRT field number was recom-
mended to be 5 or fewer in order not to increase the 
irradiated low dose volume,16 while three, five and 
seven-beam arrangements were noted to have simi-
lar MLD, V13, V20 and V30 values.21 There has 
been efforts to try decreasing the irradiated  low 
dose volume of lung such as Mayo et al using a 
hybrid –IMRT technique which combined 3-DCRT 
with IMRT, and showed to lower the contralateral 
lung V5, V13 and V20.11 Chan et al tried VMAT 
and 3-DCRT (Hybrid-rapid arc) combination, and 
Hybrid-rapid arc produced the lowest V20 and 
MLD in comparison to 3-DCRT or VMAT alone 
without any statistical difference in the low dose 
volumes like V5, V10, V15.7 We have revealed V5 
as 55%, 63%, 58.8% for IMRT, VMAT and HA-
IMRT plans, respectively. Even we have low V5 
dose levels under the criteria defined by the given 
reference19 Our results have shown the balancing 
effect of combined planning if needed in clinical 
practice. In order to fill the gap between IMRT 
and VMAT, different search has also been going 
on as Kim et al worked on increasing the angular 
sampling of radiation beams while eliminating dis-
pensable segments of the incident fields to improve 
conformity in dose distributions while maintaining 
high delivery efficiency.22 
In our planning study, we attempted to minimize 
the disadvantage of VMAT in irradiating low dose 
volume by using a combination with IMRT. HA-
IMRT seemed to be a better approach in compari-
son to the VMAT alone and IMRT alone based 
on better or similar OAR sparing and  conformal-
ity. Also better dose modulation and dose fall off 
around the PTV could be the advantange of hybrid 
treatment technique compare to VMAT.  One way 
of measuring the dose-modulation potential of a 
plan delivery modality is to consider the allowed 
number of control points, which are created by the 
TPS software and contained in a treatment plan’s 
DICOM file. Each control point specifies the state 
of the linac at a given instant of treatment such as 
jaw settings, MLC positions, MUs, gantry angle 
and rotation speed. An IMRT plan and double par-
tial arc VMAT plan contain 320 and 178 control 
points, respectively while a hybrid plan contains 
818 (2x320+178 ) control points.23
This work is solely a dosimetric comparison of 
planning options. Clinical implementation would 
unfortunately require two separate physics plans 
of VMAT and IMRT to reach a composite in two 
courses. Therefore our effort was just to encourage 
thinking about the hybrid combination of IMRT 
and VMAT in future planning algorithms to com-
bine them in one fraction. We have not aimed to 
accept this combination as a standard approach to 
all cases, because it also accepts a tradeoff from 
the beginning such as compromising from the 
lower lung V5 or V10 doses in IMRT in order to 
get a faster and acceptable plan with HA-IMRT 
where we could not ensure acceptable lung doses 
in VMAT alone. However, we should emphasize 
that this combination stands as a viable option once 
required.24 
The ratio of ssIMRT to VMAT in our study is an 
improvised ratio due to the fact that planning pro-
cess can be time consuming and currently physicist 
is dependent in our planning HA-IMRT method, 
where an automatic algorithm could provide differ-
ent solutions of combinations for specific individu-
alized dosimetric endpoints requiring hybrid plan-
ning in one fraction, such as whether to prioritize 
the CI or the lung V20 or esophagus based on the 
individual tumor of the patients.
Conclusion
Our results suggest that focusing on HA-IMRT in 
near future treatment planning systems with op-
timization and delivery of arcs and static IMRT 
fields in the same fraction delivery could be a ra-
tionale solution to combine the benefits of ssIMRT 
and VMAT to deliver a faster, more conformal, and 
homogeneous treatment in comparison to ssIMRT 
and to irradiate less amount of lung to a lower dose 
in comparison to VMAT.
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